Dopamine has initiated a partnership with Vault AI to improve its content offering approach using assistance from targeted consumer data analysis innovation in content qualitative research. “Vault is a valuable tool that delivers content drivers oriented to business forecasts. It is a very modern and different system, that allows us to observe the impact of shifts and approaches regarding the client’s goals,” Fidela Navarro said.
The Mexican-based subdivision of Grupo Salinas serves as the first in the Latin American region to incorporate analysis technics oriented to the assessment of ideas and concepts, and their business opportunities. “We have been working with their team for a while, and it has been very interesting and fulfilling to pay attention to the results,” Navarro continued. “Besides, we are the only Latin American company in the independent scene using this system.”
Dopamine was created in October 2017 as the audiovisual content studio of Grupo Salinas, focused on the creation, development, and production of original content for global platforms, under any type of management, business model, and partnership. “Dopamine is on the leading edge of innovation and bringing unique content to global audiences. We are proud to work in close collaboration with Dopamine to help visualize global audiences at any stage of the content’s lifecycle,” said David Stiff, CEO, Vault AI.
The studio produced the series "Hernán" in 2019 as well as family drama "Amarres," also receiving credit for the thriller "Tu parte del Trato." The establishment recently wrapped up "Búnker" for HBO Max and "40 no es nada," "Supertitlán" currently in development. Vault AI, based in Los Angeles has analyzed over 50,000 titles to match the content’s creative elements with the in- market consumer data from more than 60 countries.
Vault is a valuable tool that delivers content drivers oriented to business forecasts. It is a very modern and different system, that allows us to observe the impact of shifts and approaches regarding the client’s goals.” Fidela Navarro CEO, Dopamine